Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Entellus Medical

Request full access

Minimally invasive balloon dilation technologies for sinusitis

Plymouth, United KingdomFounded 2006Biotech & Life Sciences

About Entellus Medical

Entellus Medical, founded in 2006 by Thomas Ressemann and Peter Keith, is a medical technology company specializing in minimally invasive treatments for ear, nose, and throat (ENT) conditions, with a primary focus on chronic sinusitis. The company's core business revolves around developing and commercializing products for balloon sinus dilation, a procedure that reshapes sinus pathways without the need for tissue or bone removal. This approach is designed to be performed in a physician's office under local anesthesia, offering a cost-effective alternative to traditional functional endoscopic sinus surgery (FESS) with benefits such as faster recovery times and less bleeding.

The company's flagship product line is the XprESS™ Multi-Sinus Dilation System, which enables ENT physicians to open obstructed sinus drainage pathways. In addition to balloon dilation devices, Entellus developed a shaver system for more advanced procedures like polyp removal and septoplasty. The company's business model focused on selling these single-use devices and systems directly to ENT physicians and hospitals in the United States and Canada. Its primary clients are ENT specialists seeking effective and less invasive treatment options for their patients.

After its founding, Entellus Medical went public with an IPO in January 2015. In July 2017, the company acquired Spirox, Inc., which added the LATERA® Absorbable Nasal Implant to its portfolio for treating nasal airway obstruction. This acquisition was a significant milestone before another major corporate change. In December 2017, Stryker Corporation announced a definitive agreement to acquire Entellus Medical for approximately $662 million. The acquisition was completed in February 2018, and Entellus Medical became a wholly-owned subsidiary of Stryker, complementing Stryker's existing ENT business.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2015

Entellus Medical in the Plymouth ecosystem

Live from Dealroom

The Entellus Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Split Rock Partners
  • SV Health Investors

Series B and later5 investors entered at this stage

  • Greenspring Associates
  • EW Healthcare Partners
  • Essex Woodlands Health Ventures
  • Covidien Ventures
  • Oxford Finance
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · Plymouth HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Entellus Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Entellus Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.